FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37889211000001100: Yasmin tablets (CST Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
539081000001114 Yasmin tablets (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
539091000001111 Yasmin tablets (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Yasmin tablets (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Is a Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Is a Yasmin true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Yasmin tablets (CST Pharma Ltd) 63 tablet Has AMP True Yasmin tablets (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start